|
||||||||||||||||
HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
CHI's MOLECULAR ANALYSIS FOR RESEARCH AND DIAGNOSTICS | ||||||||||||||||
September 21, 2001 | ||||||||||||||||
Cambridge Healthtech Institute, Hilton San Diego Resort February 13-14, 2002 The growing momentum of genomics and molecular analysis has enormous promise for numerous drug research applications, as well as for diagnostics. Gene and protein-based assays can provide critical information, but they also raise important issues that need to be addressed if their full potential is to be realized. Analysis based on gene expression profiles may be of particular importance for improved understanding and diagnosis of disorders with the complexity of cancer. Molecular diagnostics, however, are generally viewed as expensive and labor intensive, which means that advances to improve automation, throughput, scalability and reliability are critical. Leading researchers will be covering advances, experiences and challenges relevant for each of these issues in detail, so plan to participate and gain useful new insights. |
||||||||||||||||
Organized by: | Cambridge Healthtech Institute | |||||||||||||||
Invited Speakers: | Overview: Dr. John N. Weinstein, National Cancer Institute Biomarkers Clinical Proteomics Dr. Emmanuel Petricoin, U.S. Food and Drug Administration Protein Biomarkers Dr. Gordon Holt, Oxford GlycoSciences plc TOGA™ Open System Expression Profiling for the Discovery and Validation of Biomarkers Dr. David D. Lo, Digital Gene Technologies, Inc. Herceptin and Diagnostic Assays Dr. Dennis Slamon, University of California, Los Angeles (invited) Genetic Diagnostics Studies on Genomes of Individual and Pooled Human Germline Cells: Mutation and Abnormal Recombination Dr. Norman Arnheim, University of Southern California Detection of Point Mutations in K-Ras Oncogenes Associated with Colorectal Cancer Using Modular Microfluidic Systems Dr. Steven A. Soper, Louisiana State University Preconceptional and Prenatal Carrier Screening for Cystic Fibrosis: American College of Medical Genetics Recommendations Dr. Wayne Grody, UCLA School of Medicine GeneTests and Genetic Counseling Dr. Roberta A. Pagon, University of Washington School of Medicine Genomic Competencies for the Public Health Workforce: A Model Dr. Andrew Faucett, Centers for Disease Control and Prevention Gene Expression Analysis of Gene Expression in Single Cells Dr. Ricardo V. Lloyd, Mayo Clinic Gene Expression Analysis of Human Breast Cancer Dr. Dennis Sgroi, Massachusetts General Hospital Molecular Signatures of Cancer Cells Dr. Sudhir Srivastava, National Cancer Institute Using Real-Time PCR Techniques for Tumor Profiling in the Clinical Laboratory Dr. Philip Bernard, University of Utah Health Sciences Center Industrializing Molecular Analysis Business and Financial Aspects of Molecular Diagnostics Burrill & Co. (invited) Diagnostics Innovative Interdisciplinary Approaches Dr. Alan Rudolph, Defense Advance Research Projects Agency High-Throughput Genetic Analysis Dr. Russell Higuchi, Roche Molecular Systems Applied Genomics Dr. Mark G. Erlander, Arcturus Engineering, Inc. Automated Microarray Analysis: Active Interferometric Computing across Biochip Platforms Dr. David Robbins, ViaLogy, Inc. |
|||||||||||||||
Deadline for Abstracts: | January 11, 2001 | |||||||||||||||
Registration: | http://www.chidb.com/2002/qga/qga_form.htm | |||||||||||||||
E-mail: | fvargus@healthtech.com Frederick Vargus | |||||||||||||||
Posted by: | Frederick Vargus | |||||||||||||||
Host: | wks253.healthtech.com | |||||||||||||||
|
||||||||||||||||
Generated by meetings and positions 5.0 by Kai Garlipp |